Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK™ Unit

Manufacturer
Fenwal, Inc. | Fenwal International, Inc.
Effective date
2022-11-01
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-05-31 20:44:41

Label at a glance#

ProductAnticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic
Active ingredientTRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE, ANHYDROUS CITRIC ACID, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Label structure2 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

4R0012MC, 4R0837MC, 4R0112MC

Fenwal Blood-Pack Units
Rx only
With Integral Donor Tube Using ACD or CPD and Fenwal HighFlo Needle

Instructions for Use
Collection Procedure:
Use aseptic technique.
Precaution: Do not use unless solution is clear.

1. Identify Blood-Pack unit using appropriate donor identification system. Confirm that all numbered tubing of each Blood-Pack unit contains its own identical segment numbers.
2. Adjust donor scale to desired collection weight.
3. Position primary container from donor scale as far as possible below donor arm and clamp donor tubing.
4. Following blood center procedures, apply pressure to donor's arm and disinfect site of venipuncture.
5. Remove HighFlo1 needle cover per instructions below:
a) Holding the hub and cover near the tamper-evident seal, twist cover and hub in opposite directions to break seal.
b) Remove needle cover, being careful not to drag the cover across the needle point.
Following blood center procedures, perform venipuncture, appropriately secure donor needle and/or tubing and release clamp.
6. Mix blood and anticoagulant at several intervals during collection and immediately after collection.
7. Collect the appropriate volume based on Blood-Pack unit used.
Note: The volume of anticoagulant is sufficient for the blood collection indicated on Blood-Pack unit ± 10%.
8. Apply clamp to donor tube.
9. As appropriate, release pressure on the donor's arm, collect donor samples following established procedures and withdraw donor needle.
10. Withdrawal of needle into needle guard.
Precaution: The needle guard must be held stationary while the needle is withdrawn into it.
     a) Hold sides of needle guard near the front, between the index finger and thumb. Pull the hub back smoothly until the needle is completely enclosed and securely locked into the needle guard.
     b) Confirm the needle is completely enclosed and securely locked into the needle guard.
11. Strip blood from donor tubing into container, mix and allow the tubing to refill; repeat once. Seal at X marks on donor tubing to provide numbered aliquots of anticoagulated blood for typing or crossmatching.
12. Discard needle in needle guard into an appropriate biohazardous waste container following established procedures.
13. Store filled unit between 1 and 6° C.
14. Infuse blood within 21 days of collection.
Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat.
Definition of "Controlled Room Temperature":
"A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C; and that allows for excursions between 15°C and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses. Provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40°C are permitted as long as they do not exceed 24 hours ... The mean kinetic temperature is a calculated value that may be used as an isothermal storage temperature that simulates the non isothermal effects of storage temperature variations."

Reference: United States Pharmacopeia, General Notices. United States Pharmacopeial Convention, Inc.
12601 Twinbrook Parkway, Rockville, MD.

Symbols with Definitions
4R001mc-symbols4R001mc-symbols

1 Van der Meer, P.F., & de Korte, D. "Increase of blood donation speed by optimizing the needle-to-tubing connection: an application of donation software." Vox Sanguinis 2009, 97: 21-25



4r0012mcmfr
4r0012mcmfr

Manufacturer
Fresenius Kabi AG
61346 Bad Homburg / Germany
www.fresenius-kabi.com
1-800-933-6925

© 2019 Fresenius Kabi AG. All rights reserved.

47-23-13-621 REV: A

PACKAGE/LABEL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Code 4R0012MC

1 Unit
Fresenius Kabi

Fenwal Blood-Pack Unit
Single

Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) 
For Collection of 450 mL Blood
Integral Donor Tube, 16 ga. Ultra Thin Wall Fenwal HighFlo Needle

Rx only

Each unit consists of a primary container with 63 mL of CPD solution containing 1.66 g Sodium Citrate (dihydrate) USP, 1.61 g Dextrose (monohydrate) USP, 188 mg Citric Acid (anhydrous) USP, 140 mg Monobasic Sodium Phosphate (monohydrate) USP. pH may have been adjusted with sodium hydroxide.


Sterile, non-pyrogenic fluid path.
See instructions for use.
Single Use Only

Store at Controlled Room Temperature (refer to direction insert). Protect from freezing. Avoid excessive heat.

  • Open pouch by tearing across at notch.
  • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth.
  • Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture, provided:
  • Units are not removed from foil pouch, or
  • Unused units removed from foil pouch are returned to the foil pouch within 12 hours. Units may be removed from the pouch and returned only once.
  • Units removed from the foil pouch (that are not returned to the pouch within 12 hours) must be used within 4 days (96 hours). Units out of the foil pouch for longer than 96 hours must be discarded.

4r0012mclblmfg4r0012mclblmfgManufacturer
Fresenius Kabi AG
61346 Bad Homburg / Germany
www.fresenius-kabi.com
Made in US
47-28-12-703 REV: A

4r0012mclbl4r0012mclbl

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0942-9202-01Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic63 mL in 1 BAGSOLUTION638

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0942-9202ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) BLOOD-PACK UNITS IN PL 146 PLASTIC (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)) SOLUTION [FENWAL, INC.]8Current NDC, Legacy NDC, 1 package rows20221102_4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ANHYDROUS CITRIC ACIDACTIVE INGREDIENTXF417D3PSL6
DEXTROSE MONOHYDRATEACTIVE INGREDIENTLX22YL083G6
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEACTIVE INGREDIENT593YOG76RN6
TRISODIUM CITRATE DIHYDRATEACTIVE INGREDIENTB22547B95K6
Anhydrous Citric AcidACTIVE MOIETYXF417D3PSL6
ANHYDROUS DEXTROSEACTIVE MOIETY5SL0G7R0OK6
PHOSPHATE IONACTIVE MOIETYNK08V8K8HR6
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0942-92020942-9202-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAVENOUS2.78 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAVENOUS2.78 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 PlasticANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)Fenwal, Inc.4a08a9ec-46a5-4fcf-80ee-5c33f1a8b7462022-11-01Exact identifier
ndc (package): 0942-9202-01
ndc (product): 0942-9202
ndc11 (package): 00942920201
spl id: d5d9902d-5b55-4a6e-88f1-293b1cf1ed75
spl set id: 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.